Effect of formulation and processing variables on the particle size of sorbitan monopalmitate niosomes
Main Article Content
Abstract
Formulation and processing factors affect greatly the physical characteristics of the resulted nanosystems. Therefore, the present work was adopted to investigate how proper manipulation of various formulations and processing factors on vesicular Z-average particle size. The selected variables were membrane additives, [including cholesterol (CHO), dicetylphosphate (DCP) and stearylamine (SA)], sonication time as well as drug loading factor (using mannitol and estradiol). Sorbitan monopalmitate (span 40) niosomes were prepared by the conventional thin film hydration method. Particle size, measured by
Photon Correlation Spectroscopy, and polydispersity indices were measured and compared.The results indicated that CHO increased the vesicular size, with 2:1 and 1:1 (span 40:CHO) ratios showing the same size. Sonication reduced the vesicle size by 23, 35 and 42% after 10, 20 and 30 min, respectively. After 30 min, the effect of sonication was minor. The addition of charge inducing agents changed the zeta potential depending on the type of the additives. Surface charge increased the size by 24 and 11% when using DCP and SA, respectively. Drug incorporation increased the vesicle size to an extent based on its aqueous solubility. There were about 35 and 6.2% increase in vesicular size for estradiol and mannitol, respectively, supporting the partitioning of lipophilic drug within the fatty acyl side chains of the bilayer membrane.
Downloads
Article Details
This is an Open Access article distributed under the terms of the Attribution-Noncommercial 4.0 International License [CC BY-NC 4.0], which requires that reusers give credit to the creator. It allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, for noncommercial purposes only.
References
Couvereur P, Fattal E, Andremont A. Liposomes and nanoparticles in
the treatment of intracellular bacterial infections. Pharm Res 1991;8:
-86.
Choi MJ, Maibach HI. Liposomes and niosomes as topical drug delivery
systems. Skin Pharmacol Physiol 2005;18:209-19.
Ucheghu IF, Vyas SP. Non-ionic surfactant based vesicles (niosomes) in
drug delivery. Int J Pharm 1998;172:33-70.
Hofland HEJ, Bouwstra JA, Verhoef J, Junginger HE. Niosomes: A study
of structure, stability, drug release and toxicological aspects. J Control
Release 1990;13:325-6.
Litzinger DC, Buiting AM, Vanrooijen N, Huang L. Effect of liposome
size on the circulation time and intraorgan distribution of amphipathic
poly(ethylene glycol)-containing liposomes. Biochim Biophys Acta
;1190:99-7.
Goyal P, Goyal K, Kumar SG, Singh A, Katare OP, Mishra DN. Liposomal
drug delivery systems: Clinical applications. Acta Pharm 2005;55:1-25.
Verma DD, Verma S, Blume G, Fahr A. Particle size of liposomes
influences dermal delivery of substances into skin. Int J Pharm
;258:141-51.
entjurc M, Vrhovnik K, Kristl J. Liposomes as a topical delivery system:
The role of size on transport studied by the EPR imaging method. J
Control Rel 2000;59:97-7.
Szoka FC, Milholland JD, Barza M. Effect of lipid composition and
liposome size on toxicity and in vitro fungicidal activity of liposome-
intercalated amphotericin B. Antimicrob Agents Chemother 1987;31:
–9.
Shi B, Fang C, Pei Y. Stealth PEG-PHDCA niosomes: Effects of chain length of PEG and particle size on niosomes surface properties, in vitro drug release, phagocytic uptake, in vivo pharmacokinetics and antitumor
activity. J Pharm Sci 2006;95:1873-7.
Nagayasu A, Shimooka T, Kinouchi Y, Uchiyama K, Takeichi Y, Kiwada
H. Effect of fluidity and vesicle size on antitumor activity and
mylosuppressive activity of liposomes loaded with daunorbbicin. Biol
Pharm Bull 1994;7:935-9.
Volodkin D, Mohwald H, Jean-Claude Voegel J, Ball V. Coating of
negatively charged liposomes by polylysine: Drug release study. J Contol
Rel 2007;117:111-20.
New RRC. Liposomes; A practical Approach. Oxford: Oxford University
Press; 1990.
Montengero L, Panico AM, Ventimiglia A, Bonina FP. In vitro retinoic acid release and skin permeation from different liposome formulations. Int
J Pharm 1996;133:89-6.
Essa EA, Booner M, Barry BW. Targeted transdermal delivery of drugs
using charged liposomes. PhD thesis (2003). University of Bradford
Bradford, UK;.
Needham D, Nunn RS. Elastic deformation and failure of lipid bilayer
membranes containing cholesterol. Biophys J 1990;58:997-9.
Uchegbu IF, Bouwstra JJ, Florence AT. Large disk-shaped vesicles
(discomes) in vesicle-to-micelle transitions. J Phys Chem 1992;96:
-53.
McIntosh TJ. The effect of cholesterol content on the structure of
phosphatidylcholine bilayers. Biochim Biophys Acta 1978;51:43-58.
Fang J, Hong CT, Chiu W, Wang YY. Effect of liposomes and niosomes
on skin permeation of enoxacin. Int J Pharm 2001;219:61-2.
Lopez-Pinto JM, Gonzalez-Rodriguez ML, Rabasco AM. Effect of
cholesterol and ethanol on dermal delivery from DPPC liposomes. Int
J Pharm 2005;298:1-12.
Lee SC, Lee KE, Kim JJ, Lim SH. The effect of cholesterol in the
liposome bilayer on the stability of incorporated retinol. J Liposome
Res 2005;15:157-6.
Silver L. The physical chemistry of membranes. New York, USA Alan and
Unwin and Soloman PressUchegbu IF, Florence AT. Non-ionic surfactant
vesicles (Niosomes): Physical and pharmaceutical chemistry. Adv Colloid
Interface Sci 1995;58:1-55.
Moriyam E, Saito T, Tokuoka Y, Takeuchi S, Kawashima N. Evaluation of
the hardness of lipid bilayer membranes of liposomes by the ultrasound
attenuation method. J Oleo Sci 2003;52:433-7.
Richardson ES, Pitt WG, Woodbury DJ. The role of cavitation in liposome
formation. Biophys J 2007;12:4100-7.
Brennen CE. Cavitation and bubble dynamics. New York: Oxford
University Press; 1995.
Lasic DD. The mechanism of vesicle formation. Biochem J 1988;256:1-11.
Lasic DD. Mechanisms of liposome formation. J Liposome Res
;5:431-1.
Yamaguchi T, Nomura M, Matsuoka T, Koda S. Effects of frequency and
power of ultrasound on the size reduction of liposomes. Chem Phys
Lipos 2009;160:58-2.
Krasnici S, Werner A, Martin E, Eichhorn ME, Schmitt-Sody M, Pahernik
SA, et al. Effect of the surface charge of liposomes on their uptake by
angiogenic tumor vessels. Int J Cancer 2003;105:561-7.
Li Y, Mitra AK. Effects of phospholipid chain length, concentration,
charge, and vesicle size on pulmonary insulin absorption. Pharm Res
;13:76-9.
Azmin MN, Florence AT, Handjani-Vila RM, Stuart FB, Vanlerberghe
G, Whittaker JS. The effect of non-ionic surfactant vesicles (niosome)
entrapment on the absorption and distribution of methotrexate in
mice. J Pharm Pharmacol 1985;37:237-2.
Carafa M, Santucci E, Alhaique F, Coviello T, Murtas E, Riccieri FM,
et al. Preparation and properties of new unilamellar non-ionic/ionic
surfactant vesicles. Int J Pharm 1998;160:51-9.
Van Hal DA, Bouwstra JA, Rensen AV, Jermiasse E, Vringer TD, Junginger
HE. Preparation and characterization of non-ionic surfactant vesicles.
J Colloid Interface Sci 1996;178:263-3.
Pardakhty A, Varshosaz J, Rouholamini A. In vitro study of
polyoxyethylene alkyl ether niosomes for delivery of insulin. Int J
Pharm 2007;328:130-1.
Junyapraset VB, Teeranachaideekul V, Supapem T. Effect of charged
and non-ionic membrane additives on physicochemical properties and
stability of niosomes. AAPS PharmSciTech 2008;9:851-9.
Chrai SS, Murari R, Ahmed I. Liposomes (a review). Part two: drug
delivery systems. BioPharm. 2002;15:40-9.
Schwender RA, Asanger M, Weder HG. N-alkyl-glucosides as detergents
for the preparation of highly homogenous bilayer liposomes of visible
size (60-240 nm) applying defined rates of detergent removal by dialysis.
Biochem Biophys Res Commun 1981;10:1055-2.
Gayatri DS, Venkatesh P, Udupa N. Niosomal sumatriptan succinate for
nasal administration. Indian J Phama Sci 2000;62:479-1.